Dr. Amar Sethi has been promoted to the position of chief scientific officer at Pacific Biomarkers, a Seattle-based company providing laboratory and research services for pharmaceutical and medical diagnostic manufacturers.
Pacific Biomarkers names chief scientific officer
Sethi, 40, currently the company's vice president of research and development, will replace Elizabeth Teng Leary on Jan. 1. Leary, who co-founded Pacific Biomarkers as a spinoff company from the University of Washington Lipid Research Center in 1989, will assume an advisory role and remain active in science and business development, according to a company news release.
Sethi, who earned a Ph.D. in genetic epidemiology, was a postdoctoral fellow at the National Institutes of Health's Heart, Lung and Blood Institute. His current research focus is the role of high-density lipoprotein in cardiovascular disease, according to the release.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.